RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $494 | -35.7% | 60,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $768 | -19.6% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $955 | +114.6% | 60,000 | +99.3% | 0.00% | +100.0% |
| Q4 2022 | $445 | -99.9% | 30,100 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $704,000 | +39.4% | 30,100 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $505,000 | -45.3% | 30,100 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $923,000 | +0.5% | 30,100 | -1.0% | 0.00% | 0.0% |
| Q4 2021 | $918,000 | -7.5% | 30,400 | +2.4% | 0.00% | -33.3% |
| Q3 2021 | $992,000 | -10.5% | 29,700 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,108,000 | +4.8% | 29,700 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $1,057,000 | -6.6% | 29,700 | +11.2% | 0.00% | 0.0% |
| Q4 2020 | $1,132,000 | – | 26,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,139,380 | $73,958,000 | 8.86% |
| Darwin Global Management, Ltd. | 782,471 | $27,050,000 | 5.30% |
| EcoR1 Capital, LLC | 3,429,363 | $118,553,000 | 5.26% |
| Foresite Capital Management V, LLC | 400,000 | $13,828,000 | 4.06% |
| Grace Capital | 183,112 | $6,330,000 | 4.03% |
| BVF INC/IL | 2,873,147 | $99,325,000 | 3.72% |
| Casdin Capital, LLC | 3,375,058 | $116,676,000 | 3.48% |
| Fernwood Investment Management, LLC | 185,063 | $6,398,000 | 2.35% |
| Alphabet Inc. | 1,568,486 | $54,222,000 | 2.19% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $964,675,000 | 1.67% |